Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Venomous snake" patented technology

Venomous snakes are species of the suborder Serpentes that are capable of producing venom, which they use for killing prey, for defense, and to assist with digestion of their prey. The venom is typically delivered by injection using hollow or grooved fangs, although some venomous snakes lack well-developed fangs. Common venomous snakes include the families Elapidae, Viperidae, Atractaspididae, and some of the Colubridae. The toxicity of venom is mainly indicated by murine LD₅₀, while multiple factors are considered to judge the potential danger to humans. Other important factors for risk assessment include the likelihood that a snake will bite, the quantity of venom delivered with the bite, the efficiency of the delivery mechanism, and the location of a bite on the body of the victim. Snake venom may have both neurotoxic and hemotoxic properties.

Specific primer and method for identifying bungarus multicinctus, cobra, king cobra and snake venom source species thereof and application

The invention relates to the technical field of biological medicines, and relates to specific primers and a method for identifying coral snake, cobra, king cobra and snake venom source species thereof, and application of the specific primers and the method. Based on highly-conservative and specific DNA fragments contained in DNAs extracted from tissues and snake venom of bungarus multicinctus, cobra and king cobra, specific primers are respectively designed for the fragments, and the bungarus multicinctus, cobra and king cobra and snake venom source species can be accurately identified. The method can be used for identifying bungarus multicinctus, cobra, king cobra and snake venom source species of bungarus multicinctus, cobra, king cobra and snake venom source species of bungarus multicinctus and cobra venom source species of bungarus multicinctus and cobra venom source species of bungarus multicinctus and cobra venom source species of bungarus multicinctus and cobra venom source species of bungarus multicinctus The method is high in detection sensitivity, high in correct detection rate, free of cross reaction and simple in operation process, and has higher specificity compared with a traditional immunoassay method.
Owner:WUZHOU TRADITIONAL CHINESE MEDICINE HOSPITAL

External traditional Chinese medicine preparation formula for treating limb swelling and pain after venomous snake bites and preparation method of external traditional Chinese medicine preparation formula

PendingCN121371083AAntipyreticAnalgesicsBiotechnologyVenomous snake bite
The invention discloses an external traditional Chinese medicine preparation formula for treating limb swelling and pain after venomous snake bites. The external traditional Chinese medicine preparation formula is characterized by comprising the following raw materials in parts by weight: 5-7 parts of paris polyphylla, 5-7 parts of Chinese lobelia, 2-4 parts of plantain herb, 2-4 parts of radix angelicae, 5-7 parts of lalang grass rhizome, 5-7 parts of hypericum japonicum, 4-6 parts of moutan bark, 4-6 parts of rheum officinale and 4-6 parts of golden cypress. The traditional Chinese medicine raw materials in scientific proportion are combined with a standard preparation process, through the synergistic effect of the composite efficacy module, the core problem that an existing external snake wound medicine is insufficient in pertinence and weak in synergism is solved, the application scene is further expanded, the use safety is improved, and the traditional Chinese medicine composition is worthy of popularization and application. Furthermore, the treatment effect on limb swelling and pain caused by bite of agkistrodon halys, agkistrodon acutus and trimeresurus trimeresurus can be remarkably improved.
Owner:HANGZHOU TRADITIONAL CHINESE MEDICINE HOSPITAL (HANGZHOU TRADITIONAL CHINESE MEDICINE HOSPITAL AFFILIATED TO ZHEJIANG UNIV OF TRADITIONAL CHINESE MEDICINE)

A bionic microneedle continuous hair transplantation system

ActiveCN120154369BSurgeryMicroneedlesGraft transplantHair follicle
This invention discloses a biomimetic microneedle continuous hair transplant system, comprising an axially extending outer shell, a power head that moves axially relative to the outer shell at one end, and a hair follicle supply channel extending axially through the power head. Inside the outer shell are a dual-screw composite seat and a motor for controlling the rotation of the dual-screw composite seat. The dual-screw composite seat includes a base body, one end of which has a first screw and a second screw with unequal pitch. A first screw nut is threaded onto the first screw, and a second screw nut is threaded onto the second screw. The second screw nut is connected to the power head. A push rod extending into the hair follicle supply channel is provided on the first screw nut. A hollow implantation needle extending axially through the power head is provided, with its rear end connected to the front end of the hair follicle supply channel. The microneedles of this system adopt a biomimetic design inspired by snake teeth and bee stings, effectively reducing puncture force and patient pain. The system is functionally complete and highly practical.
Owner:ZHEJIANG NORMAL UNIV +1

Detection and therapeutic anti-naja naja atra venom antibodies and uses thereof

PendingCN122277740AAntigen Binding FragmentNaja naja atra venom
This invention belongs to the field of biotechnology and discloses a detectable and therapeutic antibody against the venom of the Chinese cobra and its uses. This invention provides an antibody or its antigen-binding fragment that can target and recognize different key toxin components or antigenic epitopes in venom, exhibiting excellent diagnostic specificity and therapeutic and preventative capabilities. Utilizing the high specificity of this antibody or its antigen-binding fragment in recognizing snake venom antigens, it can be developed into a rapid detection kit (such as a lateral flow immunochromatographic test strip) for rapid identification of the biting snake species and detection of the presence of specific snake venom in the environment or sample, providing crucial technical support for precise treatment and on-site diagnosis. It can also be used directly as a neutralizing agent for emergency treatment after snakebite. Through injection, the antibody can specifically neutralize the snake venom toxins entering the body, blocking its toxic effects and providing a novel and specific treatment method for clinical care.
Owner:THE HONG KONG UNIV OF SCI & TECH +1